India And Russia To Ink First Biotech Collaboration
This article was originally published in PharmAsia News
Executive Summary
MOSCOW - Looking to revitalize its biotech industry, Russia is turning eastward to Asia, as it strengthens ties and enhances information exchanges with India
You may also be interested in...
Russia Attracts More Multinational Pharmas As Emerging Markets Continue To Bloom
Indian drug maker Ranbaxy is moving swiftly to capitalize on Russian policies to encourage establishing a local production presence, signing a memorandum of understanding with Russia's Yaroslavl regional authority to help the province build a medical and pharmaceutical center. The "going local, going to regions" move could set a model for international pharma companies eying the Russian market, says a Russia biologics expert
Russia Attracts More Multinational Pharmas As Emerging Markets Continue To Bloom
Indian drug maker Ranbaxy is moving swiftly to capitalize on Russian policies to encourage establishing a local production presence, signing a memorandum of understanding with Russia's Yaroslavl regional authority to help the province build a medical and pharmaceutical center. The "going local, going to regions" move could set a model for international pharma companies eying the Russian market, says a Russia biologics expert
Beyond BRIC: 'Pharmerging' Markets Loom If Pharma Is To Expand, IMS Study Says
Drug makers need to more aggressively target so-called "pharmerging" markets - but not just the usual suspects. Brazil, Russia, India and China remain highly important, but in a March 16 report, IMS Health predicts that 17 countries, in total, will contribute 48 percent of annual market growth in 2013, up from 37 percent last year